Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery

BACKGROUND AND AIM: Advanced gastric cancer accounts for a substantial portion of cancer-related mortality worldwide. Surgical intervention is the curative therapeutic approach, but patients with advanced gastric cancer are not eligible for the radical resection. The present work aimed to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Feng, Ye, Gao, Yongjian, Hou, Ruizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789894/
https://www.ncbi.nlm.nih.gov/pubmed/27095004
http://dx.doi.org/10.2147/OTT.S99684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789894/
https://www.ncbi.nlm.nih.gov/pubmed/27095004
http://dx.doi.org/10.2147/OTT.S99684

Ejemplares similares